CPT® Code 43239

Quick Reference

• Code definition: CPT 43239 covers a flexible, transoral esophagogastroduodenoscopy (EGD) in which one or more biopsy specimens are obtained from anywhere in the examined upper GI tract during a single session.
• Key billing rule: Report 43239 once per endoscopic session regardless of the number of biopsy specimens taken or the number of anatomical sites sampled. MUE = 1; billing multiple units results in automatic denial [3].
• Modifier essentials: Do NOT append modifier 51 (the multiple procedure indicator is 3, endoscopy differential rule, not the standard 50% reduction). Use modifier 25 when a significant, separately identifiable E/M for an unrelated problem is documented the same day. Use modifier 59/XS when billing alongside a different endoscopic family (e.g., colonoscopy).
• Documentation must-have: The procedure report must confirm the scope advanced to at least the duodenum. Without this, payers may downcode to an esophagoscopy code (43191 to 43232 range).
• Top confusion point: Billing 43235 alongside 43239 is the single most common bundling error. 43235 is the endoscopic base code and is always included in 43239; it must never appear on the same claim for the same session [2].
• Payer alert: Site-of-service significantly affects payment. The 2026 Medicare non-facility total RVU (12.54) is more than three times the facility RVU (3.70), translating to approximately $419 non-facility versus $124 facility payment. Reporting the wrong place of service creates significant overpayment or underpayment exposure [1].
• Sedation change (2017): Moderate sedation is no longer bundled into 43239. When the performing endoscopist administers moderate sedation, separately report 99152 and 99153.

When to Use This Code

Clinical Indications

43239 applies whenever a flexible transoral EGD includes tissue sampling by biopsy forceps (cold or hot) from one or more sites. Common clinical indications from the research include:

• Suspected or confirmed celiac disease (duodenal mucosal biopsy for villous atrophy; standard protocol requires at least four specimens)
• Barrett's esophagus surveillance (four-quadrant sampling per Prague classification protocol)
• Suspected eosinophilic esophagitis (esophageal biopsy for eosinophil count; proximal and distal samples typically required)
• H. pylori evaluation (antral biopsy for CLO test or histology)
• GERD with complications, including reflux esophagitis assessment
• Upper GI bleeding workup when biopsies of ulcer margins are taken to rule out malignancy
• Evaluation of dyspepsia, epigastric pain, or unexplained weight loss where tissue sampling is warranted

Scope Boundaries

The procedure must advance to at least the duodenum to qualify as an EGD. If the scope does not pass beyond the gastroesophageal junction into the stomach and duodenum, use esophagoscopy codes (43191 to 43232) instead. The transoral approach is required; transnasal esophagoscopy uses a different code family.

43239 does not specify a maximum number of specimens or sites. All biopsies taken during a single EGD session, regardless of technique (cold forceps, hot forceps), are captured under this single code.

Provider and Setting Context

43239 is a physician service code (PC/TC indicator 0); no professional/technical component split applies. The code is payable in office (POS 11), hospital outpatient (POS 22), hospital inpatient (POS 21), and ASC (POS 24) settings. It is on the Medicare ASC-covered surgical procedure list (CY 2007 basis), with facility payment based on OPPS relative payment weight [1].

Code Differentiation Table

The critical differentiator between 43239 and 43254 is technique and intent. Standard cold or hot forceps biopsies for tissue sampling are 43239. EMR (43254) involves a resection technique designed to remove larger mucosal lesions in their entirety, typically using cap suction, submucosal injection, and electrosurgical cutting. Using 43254 for routine forceps biopsies is upcoding; the distinction is in the operative note's description of technique and equipment used [2].

Billing and Modifier Rules

Endoscopy Multiple Procedure Rule

When two or more EGD family codes are billed on the same date, CMS applies the endoscopy differential rule (multiple procedure indicator 3), not the standard 50% reduction:

• The highest-RVU EGD code is paid at 100%
• Each additional EGD code is paid at the difference between its RVU and the base code (43235) RVU

For example, when 43251 (work RVU 3.38) and 43239 (work RVU 2.33) are performed together, 43251 is paid at 100%; 43239 is paid at 2.33 minus 2.04 (43235 base RVU) = 0.29 work RVU increment only. This substantially affects reimbursement calculations when planning multi-service EGD sessions [1].

Modifier Summary

MUE and Units

MUE = 1, MAI 2 (Policy, Anatomic Consideration), effective April 1, 2026. Submitting more than one unit of 43239 per date of service will trigger automatic denial. This applies per beneficiary per date; it is not possible to stack units across multiple biopsy sites [3].

Pathology Pairing

88305 (Level IV surgical pathology, gross and microscopic) is separately reportable by pathology for GI mucosal biopsies submitted for histologic analysis. The endoscopist and the pathologist each bill their respective components independently.

Documentation Essentials

Required Elements

The procedure note for 43239 must establish:

1. Transoral approach and flexible endoscope specified
2. Extent of examination: explicit confirmation the scope was advanced through the pylorus into the duodenum (or further) to distinguish EGD from esophagoscopy
3. Findings at each anatomical region: esophagus, gastroesophageal junction, stomach (cardia, fundus, body, antrum), and duodenum
4. Biopsy details: sites from which specimens were obtained, number of specimens per site, and method (cold forceps, hot forceps, directed vs random)
5. Specimen disposition: sent to pathology for histology, CLO test, or other analysis
6. Sedation documentation: type of sedation, who administered it, duration (if moderate sedation billed separately)
7. Indication and medical necessity: clinical reason supporting biopsy at the documented sites

Audit Red Flags

Auditors specifically target:

• Missing duodenal documentation: If the report does not confirm advancement to the duodenum, the service may be downcoded to the esophagoscopy family.
• Generic indication: A note documenting only "GERD" without explanation of why biopsy was clinically necessary creates medical necessity exposure, particularly for K21.9 (GERD without esophagitis) paired with 43239.
• Barrett's without protocol documentation: Surveillance biopsies require documentation of the segment length (Prague classification C and M criteria) and the number/location of specimens relative to the established protocol. Deviating from protocol without explanation invites frequency denial.
• Celiac protocol completeness: The standard of care requires at least four specimens from the distal duodenum and two from the duodenal bulb. Notes documenting fewer specimens may face coverage challenge.

Medicare, Commercial and Medicaid Payer Rules

Medicare

43239 is an active CPT code with global days 000 (endoscopic or minor procedure). The 000-day global means postoperative visits within the endoscopy global period are included; unrelated visits are separately billable [1].

Site-of-service payment (2026 Medicare national rates):

The conversion factor for 2026 is $33.4009 [1].

Coverage is governed by MAC-specific Local Coverage Determinations for upper GI endoscopy. Applicable MACs include Novitas Solutions (Jurisdictions H and L), CGS Administrators (Jurisdictions 15 and J), WPS (Jurisdictions 5 and 8), Noridian (Jurisdictions E and F), Palmetto GBA, and NGS. Coders must consult the specific LCD in effect for their MAC jurisdiction, as medical necessity criteria and frequency limitations vary by contractor.

Medicare does not impose a national frequency limitation for diagnostic EGD. However, MAC LCDs commonly tie Barrett's esophagus surveillance frequency to dysplasia grade. For Barrett's without dysplasia, surveillance intervals of 3 to 5 years are consistent with clinical guidelines; more frequent EGDs require documentation explaining clinical deviation from standard intervals.

APC status indicator for 43239 is "Procedure or Service, Multiple Reduction Applies," consistent with the endoscopy multiple procedure rule in both the PFS and OPPS contexts [1].

Commercial Payers

Commercial payers generally follow CPT and CMS bundling logic for 43239 but may differ on:

• Prior authorization: Many commercial plans require prior authorization for elective EGD, particularly in non-urgent outpatient settings. Absence of authorization is a distinct denial cause separate from coding errors.
• Bundling with moderate sedation: Some commercial contracts bundle moderate sedation into the procedural payment and will deny separately submitted 99152/99153 without modifier or documentation support; verify plan-specific policy before billing sedation separately.
• Medical necessity thresholds: Commercial payers may apply more restrictive clinical criteria for surveillance biopsies (e.g., Barrett's screening in younger patients or shorter segments); confirm active authorization and diagnosis alignment before submission.

Common Denials and Prevention

Bundling: 43235 billed with 43239 This denial occurs when claims management systems or coders unfamiliar with endoscopy logic submit both the base diagnostic code and the biopsy code. CMS NCCI edits will bundle 43235 into 43239; the claim will pay 43239 only or deny the 43235 line. Prevention: remove 43235 from all claims that include any higher-level EGD code, including 43239 [2].

Units > 1 denied (MUE exceeded) Occurs when a coder bills one unit per specimen or one unit per biopsy site. MUE = 1 for 43239; any claim line with quantity 2 or more is denied outright with no appeal value for the additional units [3]. Prevention: code 43239 once per EGD session; document all specimens in the procedure note but bill the code once.

Downcode to esophagoscopy family Auditors and payer edits may downcode to 43200 series if the procedure note does not document advancement to the duodenum. Prevention: the endoscopist's dictation must explicitly state that the scope was advanced through the pylorus into the duodenum.

Medical necessity denial Occurs when the diagnosis code does not support the clinical need for biopsy, or when the procedure is performed outside an LCD-defined indication. For example, billing 43239 with only a symptom code (dyspepsia, K30) for a patient with a prior normal EGD may not satisfy MAC criteria without documented interval change in symptoms or new risk factors. Prevention: ensure the primary diagnosis reflects the specific indication that drove the decision to biopsy, and document the clinical rationale in the procedure note.

Upcoding audit: 43239 vs 43254 OIG and RAC auditors compare technique documentation against the billed code. Claims for 43254 (EMR) that lack documentation of cap-assisted resection or submucosal injection may be downcoded to 43239. Conversely, if a coder bills 43254 for what the note describes as forceps biopsies, this is upcoding. Prevention: confirm that the technique documented in the operative report matches the billed code before submission.

Coding Scenarios

Scenario 1: Celiac disease evaluation with multiple duodenal biopsies

A 28-year-old female with chronic diarrhea and positive tTG-IgA undergoes EGD. The gastroenterologist advances to the second portion of the duodenum and obtains four biopsies from the distal duodenum and two from the duodenal bulb. Moderate sedation is administered by the gastroenterologist for 18 minutes.

Correct coding: 43239 + 99152 + K90.0; 88305 by pathology

Why: 43239 is reported once regardless of six total specimens. 99152 is reported separately because moderate sedation is no longer bundled since 2017; at 18 minutes, only the first-interval code is warranted (the additional 15-minute add-on threshold is not met). Do not bill 43235.

Scenario 2: EGD with biopsy and polypectomy at separate sites

A 55-year-old patient undergoes EGD for dyspepsia. Antral biopsies are taken for H. pylori evaluation. Separately, a 6mm pedunculated gastric body polyp is removed by snare.

Correct coding: 43251 (primary, highest-value EGD code, paid at 100%) + 43239 (endoscopy multiple procedure rule applies; paid at differential: 43239 RVU minus 43235 base RVU) + K30

Why: Both services are separately reportable because they involve distinct procedures at distinct sites. Modifier 51 is not appended; CMS applies the endoscopy differential automatically. 43251 leads because it carries the higher RVU.

Scenario 3: Barrett's esophagus surveillance at hospital outpatient

A 62-year-old male with known Barrett's esophagus (2 cm segment, no prior dysplasia) presents for scheduled surveillance EGD at a hospital outpatient department. Four-quadrant biopsies are taken every 2 cm per protocol.

Correct coding: 43239 (POS 22, facility RVU applies) + K22.70; 88305 by pathology

Why: Site of service drives the RVU applied; at POS 22 (hospital outpatient), the facility total RVU ($124) applies, not the non-facility rate ($419). The procedure note must document the Prague segment length and biopsy protocol to support MAC LCD frequency criteria.

Scenario 4: EGD with same-day E/M for unrelated problem

A gastroenterologist performs an office EGD with biopsy for a patient with GERD. During the same encounter, the patient presents a new complaint of knee pain. The physician documents a separately identifiable E/M addressing the knee.

Correct coding: 43239 (POS 11) + 99213-25 or 99214-25 + K21.9 for 43239; musculoskeletal diagnosis for the E/M

Why: The global period for 43239 is 000. An E/M for a separate, unrelated problem is billable on the same date with modifier 25, provided the documentation clearly delineates the two distinct clinical problems and the E/M meets the applicable level requirements on its own merits.

Related Codes

• 43235 — EGD, diagnostic; endoscopic base code, always bundled into 43239
• 43251 — EGD with snare polypectomy; separately reportable with 43239 under multiple endoscopy rules
• 43254 — EGD with EMR; higher-complexity lesion resection; not interchangeable with forceps biopsy
• 43255 — EGD with control of bleeding; therapeutic code; 43239 may be add-on when biopsy also performed
• 43250 — EGD with cautery of tumor/polyp; separately reportable therapeutic service
• 88305 — Level IV surgical pathology; separately billed by pathology for submitted GI biopsy specimens
• 99152 — Moderate sedation, first 15 min; separately reportable by endoscopist when sedation is self-administered
• K22.70 — Barrett's esophagus without dysplasia; primary surveillance biopsy indication
• K90.0 — Celiac disease; duodenal biopsy is the diagnostic standard
• K20.0 — Eosinophilic esophagitis; biopsy required for diagnosis

Sources

1. CMS Physician Fee Schedule — 2026 Relative Value Files — CMS; 2026 PFS national RVU file (PPRRVU2026_Jan_nonQPP.csv); source of RVUs, payment indicators, global periods, endoscopic base code, and site-of-service differentials for 43239.
2. CMS Physician Fee Schedule — 2025 Relative Value Files — CMS; 2025 PFS national RVU file (PPRRVU25_JAN.csv); year-over-year comparison confirming 43235 as endoscopic base code for the EGD family.
3. CMS NCCI — Medically Unlikely Edits (MUEs) — CMS; MCR_MUE_PractitionerServices_Eff_04-01-2026.csv; MUE = 1, MAI 2 Policy, Anatomic Consideration for 43239, effective April 1, 2026.
4. CMS NCCI — Procedure-to-Procedure (PTP) Edits — CMS; current PTP edit pairs for the EGD family including 43239 and 43235 bundling.